diarrhea while on tirzepatide and Diarrhea: Managing GLP-1 Digestive Side Effects Tirzepatide Side Effects You Should

Those with existing retinopathy require closer monitoring

Long-acting GLP-1 receptor agonists provide sustained receptor activation and clinically meaningful improvements in glycaemic control and weight in eligible patients, as recognised in NICE guidance (NG28) for type 2 diabetes management

While these observational designs cannot prove causation, the consistency of findings across different databases, countries, and methodological approaches supports the reality of the effect

Contact your doctor if: Your diarrhea lasts for more than 2 days without improving

Dulaglutide shows nausea rates of approximately 8-12% at lower doses, whilst semaglutide (Wegovy) demonstrates rates around 44% in weight management trials